Sign in
TLPPF Stock Price, Chart, Stats & News
Telix Pharmaceuticals Limited
Save
Telix Pharmaceuticals Limited (TLPPF) does not currently pay a dividend.
3.90B
Market cap
–
Current P/E
277.78x
Forward P/E
TLPPF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals. The company operates through three segments: Precision Medicine, Therapeutics, and Manufacturing Solutions. Its lead therapeutic product candidate is TLX591, a lutetium-labeled radio antibody-drug conjugate (rADC), which is in a Phase 3 clinical trial in patients with advanced prostate cancer.
Similar securities
Based on sector and market capitalization
Report issue